In patients with CLL, these changes ranged from 1.30-fold for sPD-1 to 1.54-fold for sCD200, and for patients with CVID, from 1.32-fold for sCD86 to 1.86-fold for sCTLA-4. Here, HOXD13 is linked to B-cell chronic lymphocytic leukemia.